AGH ENTERPRISES LIMITED

Financial Health Assessment: AGH Enterprises Limited

1. Financial Health Score: C-

Explanation: The patient is alive and has a strong pulse (cash balance), but is suffering from internal bleeding (trading losses) and a severe blockage in its financial arteries (unpaid VAT). While the business is currently solvent, the underlying loss-making trajectory and significant tax liabilities present a serious risk of cardiac arrest if not treated promptly.

2. Key Vital Signs

• Pulse (Cash Position): £101,850
  • Interpretation: On the surface, the patient appears to have a strong heartbeat. Cash represents roughly 79% of total assets. However, this cash is heavily earmarked for outstanding liabilities, meaning the "healthy" pulse is somewhat of an illusion.
• Blood Pressure (Current Liabilities): £114,430
  • Interpretation: Dangerously high. Liabilities have almost doubled from £67,942 in 2024, putting immense pressure on the company's circulatory system. The most alarming spike is in VAT owed, which has jumped to £39,091 from zero the previous year.
• Cholesterol/Artery Plaque (Director's Loan): £61,940
  • Interpretation: The director is acting as the company's life support, injecting funds to keep it afloat. However, the lack of interest and formal repayment terms on this large loan creates a long-term blockage in the company's financial planning.
• Weight Loss (Retained Earnings): -£8,183
  • Interpretation: The company has shed financial weight, dropping from £22,383 in retained earnings to £14,200. This confirms the business operated at a loss during the year. The patient is consuming its own muscle to survive.
• Immune System (Net Current Assets): £14,300
  • Interpretation: Very thin buffer. While technically positive, the margin between current assets and current liabilities is perilously slim, leaving the company highly vulnerable to any sudden shocks.

3. Diagnosis

The financial data reveals a business suffering from acute cash flow anemia masked by a temporary cash infusion.

While the balance sheet shows a positive net asset position of £14,300, this figure is entirely dependent on a large director's loan (£61,940) and masks a troubling underlying condition: the company is trading at a loss. The retained earnings have dropped, indicating that revenue is not covering costs.

The most critical symptom of distress is the sudden accumulation of VAT arrears (£39,091). In a healthy business, VAT is collected on behalf of HMRC and held separately before being passed on. The fact that this liability has ballooned suggests the company is using the taxman's money as an emergency working capital facility to fund day-to-day operations. HMRC is an aggressive creditor; if this "tumor" is not addressed, it could quickly lead to a winding-up petition, which would be fatal to the business.

Additionally, the appearance of Trade Debtors (£26,880)—up from zero the previous year—suggests that the company is struggling to collect cash from clients promptly, further exacerbating the cash flow shortage.

4. Recommendations

To restore the patient to full financial health, the following interventions are required:

1. Treat the VAT Blockage Immediately: The £39,091 owed to HMRC is a medical emergency. You must prioritize clearing this debt. If the cash at hand (£101,850) is not sufficient to clear it while paying other creditors, you should contact HMRC immediately to negotiate a "Time to Pay" arrangement before enforcement action begins.
2. Stop the Internal Bleeding (Profitability): Conduct an urgent review of pricing and overheads. The business cannot survive continuing to make losses. Identify which contracts or activities are loss-making and either renegotiate their terms or cease them entirely.
3. Improve Cash Circulation (Debtors): With £26,880 now owed by customers, implement stricter credit control procedures. Chase outstanding invoices vigorously to convert those debtors into cash, which will help alleviate the pressure on the working capital.
4. Formalize the Life Support (Director's Loan): The £61,940 owed to the director needs structure. Put a formal repayment schedule in place. This not only provides clarity for the director but also ensures the company plans for these future cash outflows rather than treating the loan as a permanent, interest-free cushion.